NCT06789081 2026-03-23
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
AHS Cancer Control Alberta
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
9 trialsNCT03960177 2026-01-07
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Active not recruiting
NCT05091866 2026-01-07
Natural Progesterone for the Treatment of Recurrent Glioblastoma
Emory University
Phase EARLY_PHASE1 Active not recruiting
NCT05488366 2025-09-22
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma
University of California, Irvine
Phase EARLY_PHASE1 Active not recruiting
NCT01189643 2025-09-05
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04457258 2025-08-12
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03463408 2025-08-11
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
University of Rochester
Phase EARLY_PHASE1 Active not recruiting
NCT04634227 2025-05-04
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
University of Iowa
Phase EARLY_PHASE1 Active not recruiting
NCT06813417 2025-04-10
SPS-Q2
University of Calgary
Phase EARLY_PHASE1 Active not recruiting